Aequus Receives Positive Formulary Decision in British Columbia for Specialty Portfolio Product
16 janv. 2020 09h15 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Jan. 16, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus to Broaden Vistitan Reimbursement for Patients in Canada
10 janv. 2020 09h15 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Jan. 10, 2020 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus and Medicom Healthcare Sign Exclusive Term Sheet To Jointly Advance Ophthalmology Products Into The USA
13 déc. 2019 10h45 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Dec. 13, 2019 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus Provides Third Quarter 2019 Financial Highlights
29 nov. 2019 16h30 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Nov. 29, 2019 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus Highlights Study Indicating Vistitan as the Most Effective Treatment for Glaucoma
18 oct. 2019 08h30 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Oct. 18, 2019 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”) today acknowledged the research results presented at...
Aequus Replaces Expired Short Form Base Shelf Prospectus
17 sept. 2019 08h45 HE
|
Aequus Pharmaceuticals
NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V :...
A Return to Revenue Growth - Aequus Provides Second Quarter 2019 Financial Highlights
27 août 2019 09h15 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus Signs Exclusive Distribution Agreement with Medicom Healthcare for Canadian Distribution Rights of Ophthalmic Products
29 juil. 2019 08h30 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, July 29, 2019 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”) is pleased to announce the signing of an exclusive...
Aequus Provides First Quarter 2019 Financial Highlights
30 mai 2019 20h00 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, May 30, 2019 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on...
Aequus to Clarify Press Release of 23rd May 2019 Relating to Zepto Capsulotomy System and Kensington Eye Institute
30 mai 2019 19h30 HE
|
Aequus Pharmaceuticals
VANCOUVER, British Columbia, May 30, 2019 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”) confirms its release of 23rd May 2019. Aequus is...